Genexine, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Bundang-Gu Korea, Republic of (1999)

Organization Overview

First Clinical Trial
2006
NCT00517569
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Genexine_Clinical Development Dept. | Genexine, Inc. | Genexine, Inc, Clinical development Department | PT Kalbe Genexine Biologics